Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Om Akay"'
Autor:
Theodoros Vassilakopoulos, B Ferhanoglu, Na Horowitz, J Apostolidis, Z Mellios, Alexia Piperidou, L Kaynar, M Zektser, A Giotasmater, Dei Hospital, Msida Malta, A Symeonidis, C Kalpadakis, A Agathocleous, Om Akay, A Sayyed, Sc Atalar, E Katodritou, T Leonidopoulou, Sg Papageorgiou, T. Tadmor, O Gutwein, S Karakatsanis, C Ganzel, G. Karianakis, G. Y. Isenberg, G Gainaru, E. Vrakidou, M Palassopoulou, M Ozgur, Marina Siakantaris, S Paydas, P Tsirigotis, M Tsirogianni, E Hatzimichael, Tf Tugular, Jv Assimakopoulos, L Ligdi, A Liaskas, Maria Aikaterini Lefaki, P Labropoulou, A Kopsaftopoulou, E Verrou, M Kanellias, P Zikos, A Koumarianou, A Gafter-Gvili, M Bouzani, Mk Angelopoulou, T Karmiris, R Gurion
Publikováno v:
HemaSphere, Vol 7, p e2522583 (2023)
Externí odkaz:
https://doaj.org/article/e7f49d13dd334155a0d83632360fc08b
Autor:
Liu, Xian-Xian, Fong, Simon James, Dey, Nilanjan, Crespo, Rubén González, Herrera-Viedma, Enrique
Publikováno v:
Applied Intelligence; Jul2021, Vol. 51 Issue 7, p4162-4198, 37p
Autor:
Richardson PG; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: paul_richardson@dfci.harvard.edu., Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain., Beksac M; Ankara University, Ankara, Turkey., Liberati AM; Università degli studi di Perugia, Perugia, Italy., Galli M; Azienda Ospedaliera Papa Giovanni XXIII, Unità Operativa di Ematologia, Bergamo, Italy., Schjesvold F; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway; K G Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway., Lindsay J; East Kent Hospitals University NHS Foundation Trust, Kent and Canterbury Hospital, Canterbury, UK., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., White D; Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada., Facon T; University of Lille, Centre Hospitalier Universitaire Lille, Service des Maladies du Sang, Lille, France., San Miguel J; Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain., Sunami K; National Hospital Organization Okayama Medical Center, Okayama, Japan., O'Gorman P; Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland; Cancer Trials Ireland, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland., Sonneveld P; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Robak P; Medical University of Lodz, Lodz, Poland., Semochkin S; Pirogov Russian National Research Medical University, Moscow, Russia., Schey S; Department of Hematology, King's College London, London, UK., Yu X; Celgene Corporation, Summit, NJ, USA., Doerr T; Celgene Corporation, Summit, NJ, USA., Bensmaine A; Celgene International, Boudry, Switzerland., Biyukov T; Celgene International, Boudry, Switzerland., Peluso T; Celgene International, Boudry, Switzerland., Zaki M; Celgene Corporation, Summit, NJ, USA., Anderson K; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Dimopoulos M; National and Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Jun; Vol. 20 (6), pp. 781-794. Date of Electronic Publication: 2019 May 13.